212
Views
4
CrossRef citations to date
0
Altmetric
Original Article

Etanercept protects myocutaneous flaps from ischaemia reperfusion injury: An experimental study in a rat tram flap model

, &
Pages 208-215 | Received 13 Nov 2015, Accepted 08 Jan 2016, Published online: 07 Mar 2016

References

  • Siemionow M, Arslan E. Ischemia/reperfusion injury: a review in relation to free tissue transfers. Microsurgery 2004;24:468–75.
  • Wang WZ. Investigation of reperfusion injury and ischemic preconditioning in microsurgery. Microsurgery 2009;29:72–9.
  • Rücker M, Schäfer T, Roesken F, et al. Reduction of inflammatory response in composite flap transfer by local stress conditioning-induced heat-shock protein 32. Surgery 2001;129:292–301.
  • Cetinkale O, Bilgic L, Bolayirli M, et al. Involvement of neutrophils in ischemia-reperfusion injury of inguinal island skin flaps in rats. Plast Reconstr Surg 1998;102:153–60.
  • Eltzschig HK, Collard CD. Vascular ischaemia and reperfusion injury. Br Med Bull 2004;70:71–86.
  • Yang M, Chen J, Zhao J, Meng M. Etanercept attenuates myocardial ischemia/reperfusion injury by decreasing inflammation and oxidative stress. PLoS One 2014;9:e108024
  • Berry MF, Woo YJ, Pirolli TJ, et al. Administration of a tumor necrosis factor inhibitor at the time of myocardial infarction attenuates subsequent ventricular remodeling. J Heart Lung Transplant 2004;23:1061–8.
  • Jazwinski AB, Jezsik J, Ardoin SP, et al. Etanercept treatment to enable successful hepatitis C virus clearance in a patient with rheumatoid arthritis. Gastroenterol Hepatol 2011;7:772–4.
  • Venegas-Pont M, Manigrasso MB, Grifoni SC, et al. Tumor necrosis factor-alpha antagonist etanercept decreases blood pressure and protects the kidney in a mouse model of systemic lupus erythematosus. Hypertension 2010;56:643–9.
  • Elliott MJ, Maini RN, Feldmann M, et al. Repeated therapy with monoclonal antibody to tumour necrosis factor alpha (cA2) in patients with rheumatoid arthritis. Lancet 1994;344:1125–7.
  • Zou JX, Braun J, Sieper J. Immunological basis for the use of TNFalpha-blocking agents in ankylosing spondylitis and immunological changes during treatment. Clin Exp Rheumatol 2002;20:34–7.
  • Giannini EH, Ilowite NT, Lovell DJ, et al. Long-term safety and effectiveness of etanercept in children with selected categories of juvenile idiopathic arthritis. Arthritis Rheum 2009;60:2794–804.
  • Naidu BV, Farivar AS, Woolley SM, et al. Novel broad-spectrum chemokine inhibitor protects against lung ischemia- reperfusion injury. J Heart Lung Transplant 2004;23:128–34.
  • Ersoy B, Sirinoğlu H, Bayramiçli M. A new role for hygienic pad in the laboratory settings. Microsurgery 2010;30:422.
  • Edmunds MC, Wigmore S, Kluth D. In situ transverse rectus abdominis myocutaneous flap: a rat model of myocutaneous ischemia reperfusion injury. J Vis Exp 2013;50473.
  • Bayramiçli M, Yilmaz B, Numanoğlu A. Modified protective rat vest. Plast Reconstr Surg 1998;101:859–60.
  • Hillegass LM, Griswold DE, Brickson B, Albrightson-Winslow C. Assessment of myeloperoxidase activity in whole rat kidney. J Pharmacol Methods 1990;24:285–95.
  • Beuge JA, Aust SD. Microsomal lipid peroxidation. Meth Enzymol 1978;52:302–11.
  • Beutler E. Glutathione in red blood cell metabolism. In: Beutler E, ed. Red Cell Metabolism: A Manual of Biochemical Methods. New York: Grune and Stratton; 1975:112–14.
  • Mylroie AA, Collins H, Umbles C, Kyle J. Erythrocyte superoxide dismutase activity and other parameters of copper status in rats ingesting lead acetate. Toxicol Appl Pharmacol 1986;82:512–20.
  • Bar-Or D, Lau E, Winkler JV. A novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia-a preliminary report. J Emerg Med 2000;19:311–15.
  • Choi DE, Jeong JY, Lim BJ, et al. Pretreatment with the tumor nerosis factor-alpha blocker etanercept attenuated ischemia-reperfusion renal injury. Transplant Proc 2009;41:3590–6.
  • Doetsch PW, Cunningham RP. The enzymology of apurinic/apyrimidinic endonucleases. Mutat Res 1990;236:173–201.
  • Celik B, Yardan T, Kefeli M, et al. Diagnostic value of ischaemia-modified albumin in pulmonary contusion in rats. Injury 2012;43:357–61.
  • Turedi S, Cinar O, Kaldirim U, et al. Ischemia-modified albumin levels in carbon monoxide poisoning. Am J Emerg Med 2011;29:675–81.
  • Carrol WR, Esclamado RM. Ischemia/reperfusion injury in microvascular surgery. Head Neck 2000;22:700–13.
  • Phelps DB, Rutherford RB, Boswick JA. Control of vasospasm following trauma and microvascular surgery. J Hand Surg 1979;4:109–17.
  • Hirigoyen MB, Zhang W, Gordon RE, et al. Additional benefit of heparin in the thrombolytic salvage of ischemic skin flaps. Ann Plast Surg 1995;35:612–19.
  • Hong JP, Kwon H, Chung YK, Jung SH. The effect of hyperbaric oxygen on ischemia-reperfusion injury: an experimental study in a rat musculocutaneous flap. Ann Plast Surg 2003;51:478–87.
  • Reilly PM, Schiller HJ, Bulkley GB. Pharmacologic approach to tissue injury mediated by free radicals and other reactive oxygen metabolites. Am J Surg 1991;161:488–503.
  • Cinpolat A, Bektas G, Coskunfirat N, et al. Comparing various surgical delay methods with ischemic preconditioning in the rat TRAM flap model. J Reconstr Microsurg 2014;30:335–42.
  • Ceylan R, Kaya B, Çaydere M, et al. Comparison of ischaemic preconditioning with surgical delay technique to increase the viability of single pedicle island venous flaps: an experimental study. J Plast Surg Hand Surg 2014;48:368–74.
  • Li X, Cooley BC, Fowler JD, Gould JS. Intravascular heparin protects muscle flaps from ischemia/reperfusion injury. Microsurgery 1995;16:90–3.
  • Cahoon NJ, Naparus A, Ashrafpour H, et al. Pharmacologic prophylactic treatment for perioperative protection of skeletal muscle from ischemia-reperfusion injury in reconstructive surgery. Plast Reconstr Surg 2013;131:473–85.
  • Duehrkop C, Denoyelle J, Shaw S, Rieben R. Use of dextran sulfate in tourniquet-induced skeletal muscle reperfusion injury. J Surg Res 2014;187:150–61.
  • Salloum FN, Das A, Samidurai A, et al. Cinaciguat, a novel activator of soluble guanylate cyclase, protects against ischemia/reperfusion injury: role of hydrogen sulfide. Am J Physiol Heart Circ Physiol 2012;302:H1347–54.
  • Batista ML, Jr, Rosa JC, Lopes RD, et al. Exercise training changes IL-10/TNF-alpha ratio in the skeletal muscle of post-MI rats. Cytokine 2010;49:102–8.
  • Azuma H, Nadeau K, Takada M, et al. Cellular and molecular predictors of chronic renal dysfunction after initial ischemia/reperfusion injury of a single kidney. Transplantation 1997;64:190–7.
  • Meldrum DR, Cleveland JC, Jr, Cain BS, et al. Increased myocardial tumor necrosis factor-alpha in a crystalloid-perfused model of cardiac ischemia-reperfusion injury. Ann Thorac Surg 1998;65:439–43.
  • Rodrigo R, Libuy M, Feliu F, Hasson D. Oxidative stress-related biomarkers in essential hypertension and ischemia-reperfusion myocardial damage. Dis Markers 2013;35:773–90.
  • Black SC, Rodger IW. Methods for studying experimental myocardial ischemic and reperfusion injury. J Pharmacol Toxicol Methods 1996;35:179–90.
  • Su H, Sun X, Ma H, et al. Acute hyperglycemia exacerbates myocardial ischemia/reperfusion injury and blunts cardioprotective effect of GIK. Am J Physiol Endocrinol Metab 2007;293:E629–35.
  • Donnahoo KK, Meng X, Ayala A, et al. Early kidney TNF-alpha expression mediates neutrophil infiltration and injury after renal ischemia-reperfusion. Am J Physiol 1999;277:R922–9.
  • Khimenko PL, Bagby GJ, Fuseler J, Taylor AE. Tumor necrosis factor-alpha in ischemia and reperfusion injury in rat lungs. J Appl Physiol (1985) 1998;85:2005–11.
  • Loh KP, Huang SH, De Silva R, et al. Oxidative stress: apoptosis in neuronal injury. Curr Alzheimer Res 2006;3:327–37.
  • Manzanero S, Santro T, Arumugam TV. Neuronal oxidative stress in acute ischemic stroke: sources and contribution to cell injury. Neurochem Int 2013;62:712–18.
  • Taylor JM, Crack PJ. Impact of oxidative stress on neuronal survival. Clin Exp Pharmacol Physiol 2004;31:397–406.
  • Ricart-Jane D, Llobera M, Lopez-Tejero MD. Anticoagulants and other pre-analytical factors interfere in plasma nitrate/nitrite quantification by the Griess method. Nitric Oxide 2002;6:178–85.
  • Candelario-Jalil E, Mhadu NH, Al-Dalain SM, et al. Time course of oxidative damage in different brain regions following transient cerebral ischemia in gerbils. Neurosci Res 2001;41:233–41.
  • Niizuma K, Yoshioka H, Chen H, et al. Mitochondrial and apoptotic neuronal death signaling pathways in cerebral ischemia. Biochim Biophys Acta 2010;1802:92–9.
  • de Souza-Pinto NC, Eide L, Hogue BA, et al. Repair of 8-oxodeoxyguanosine lesions in mitochondrial DNA depends on the oxoguanine dna glycosylase (OGG1) gene and 8-oxoguanine accumulates in the mitochondrial DNA of OGG1-defective mice. Cancer Res 2001;15:5378–81.
  • Yue R, Xia X, Jiang J, et al. Mitochondrial DNA oxidative damage contributes to cardiomyocyte ischemia/reperfusion-injury in rats: cardioprotective role of lycopene. J Cell Physiol 2015;230:2128–41.
  • Mentese A, Turkmen S, Karaguzel E, et al. The predictive value of ischemia-modified albumin in long-term results of ischemia-reperfusion injury in an experimental testicular torsion model. Urology 2012;80:689–94.
  • Acar Y, Bozkurt M, Firat U, et al. A comparison of the effects of epidural and spinal anesthesia with ischemia-reperfusion injury on the rat transverse rectus abdominis musculocutaneous flap. Ann Plast Surg 2013;71:605–9.
  • Wang H, Li Z, Liu X. Effects of various protocols of ischemic preconditioning on rat tram flaps. Microsurgery 2008;28:37–43.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.